Dosing rationale using population pharmacokinetics of sotalol in children with tachycardia

被引：0
|
作者：
Läer, S
Elshoff, JP
Mir, TS
Müller-Wolf, C
Weil, J
Hulpke-Wette, M
Meibohm, B
机构：
[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Klin Pharmakol, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Abt Padiat Kardiol, D-20246 Hamburg, Germany
[3] Univ Gottingen, Abt Padiat Kardiol, D-3400 Gottingen, Germany
[4] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
441
引用
收藏
页码：R114 / R114
页数：1
相关论文
共 50 条
  • [31] Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years
    Bellanti, Francesco
    Del Vecchio, Giovanni C.
    Putti, Maria C.
    Maggio, Aurelio
    Filosa, Aldo
    Cosmi, Carlo
    Mangiarini, Laura
    Spino, Michael
    Connelly, John
    Ceci, Adriana
    Della Pasqua, Oscar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (03) : 593 - 602
  • [32] Theophylline Population Pharmacokinetics and Dosing in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass
    Frymoyer, Adam
    Su, Felice
    Grimm, Paul C.
    Sutherland, Scott M.
    Axelrod, David M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09): : 1084 - 1093
  • [33] Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
    Niu, Chang-He
    Xu, Hua
    Gao, Liu-Liu
    Nie, Ying-Ming
    Xing, Li-Peng
    Yu, Li-Peng
    Wu, San-Lan
    Wang, Yang
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [34] Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance
    He, Cui-Yao
    Ye, Pan-Pan
    Liu, Bin
    Song, Lin
    van den Anker, John
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [35] Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children
    Lv, Chun-Le
    Lu, Jie-Jiu
    Chen, Ming
    Zhang, Ren
    Li, Qiao-Chuan
    Chen, Yi-Yu
    Liu, Tao-Tao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1278 - 1287
  • [36] Population Pharmacokinetics of Gentamicin and Dosing Optimization for Infants
    Medellin-Garibay, Susanna E.
    Rueda-Naharro, Aida
    Pena-Cabia, Silvia
    Garcia, Benito
    Romano-Moreno, Silvia
    Barcia, Emilia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 482 - 489
  • [37] Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants
    Shi, Zhong-Ren
    Chen, Xing-Kai
    Tian, Li-Yuan
    Wang, Ya-Kun
    Zhang, Gu-Ying
    Dong, Lei
    Jirasomprasert, Totsapol
    Jacqz-Aigrain, Evelyne
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [38] AN IN SILICO SIMULATION STUDY OF EXTENDED INTERVAL DOSING OF ATEZOLIZUMAB USING POPULATION PHARMACOKINETICS
    Peer, C.
    Schmidt, K.
    Arisa, O.
    Richardson, W.
    Paydary, K.
    Goldstein, D.
    Figg, W.
    Ratain, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S25 - S26
  • [39] Population Pharmacokinetics and Pharmacodynamics of Sotalol in Pediatric Patients with Supraventricular or Ventricular Tachyarrhythmia
    Jun Shi
    Thomas M. Ludden
    Armen P. Melikian
    Marc R. Gastonguay
    Peter H. Hinderling
    Journal of Pharmacokinetics and Pharmacodynamics, 2001, 28 : 555 - 575
  • [40] Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia
    Shi, J
    Ludden, TM
    Melikian, AP
    Gastonguay, MR
    Hinderling, PH
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (06) : 555 - 575
12345